The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditions.

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
Alan RegenbergRichard J Traystman

Abstract

Progress in regenerative medicine seems likely to produce new treatments for neurologic conditions that use human cells as therapeutic agents; at least one trial for such an intervention is already under way. The development of cell-based interventions for neurologic conditions (CBI-NCs) will likely include preclinical studies using animals as models for humans with conditions of interest. This paper explores predictive validity challenges and the proper role for animal models in developing CBI-NCs. In spite of limitations, animal models are and will remain an essential tool for gathering data in advance of first-in-human clinical trials. The goal of this paper is to provide a realistic lens for viewing the role of animal models in the context of CBI-NCs and to provide recommendations for moving forward through this challenging terrain.

References

Aug 19, 1997·Proceedings of the National Academy of Sciences of the United States of America·J F LuK D Smith
Aug 13, 1998·Critical Care Clinics·C H Allen, J D Ward
Dec 3, 1999·Stroke; a Journal of Cerebral Circulation·UNKNOWN Stroke Therapy Academic Industry Roundtable (STAIR)
May 24, 2001·Current Opinion in Neurology·J BergerS Forss-Petter
Jul 7, 2001·Stroke; a Journal of Cerebral Circulation·UNKNOWN Stroke Therapy Academic Industry Roundtable II (STAIR-II)
Dec 26, 2001·Annual Review of Psychology·Richard J DavidsonKatherine Putnam
Jan 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Lars M BjorklundOle Isacson
Jan 24, 2002·Trends in Pharmacological Sciences·Liliana B Menalled, Marie-Françoise Chesselet
Apr 5, 2002·Trends in Genetics : TIG·David C Rubinsztein
Aug 2, 2002·Pharmacology, Biochemistry, and Behavior·Suhail Kasim, H A Jinnah
Mar 26, 2003·ILAR Journal·Richard J Traystman
Sep 4, 2003·Annals of Neurology·C Warren OlanowThomas B Freeman
Nov 11, 2003·Fertility and Sterility·Liza DawsonRuth R Faden
Nov 26, 2003·Experimental Neurology·Irene Ginis, Mahendra S Rao
Dec 4, 2003·Pharmacology & Therapeutics·A Richard GreenDavid M Jackson
Apr 22, 2004·The Journal of Allergy and Clinical Immunology·Rebecca H Buckley
Jul 13, 2004·Experimental Hematology·Jingli CaiMahendra S Rao
Oct 12, 2004·Trends in Neurosciences·Michael S LevineMarie-Françoise Chesselet
Jan 25, 2005·Mental Retardation and Developmental Disabilities Research Reviews·Jacqueline N Crawley
Feb 18, 2005·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Yu Dennis ChengJustin A Zivin
Feb 18, 2005·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Olle Lindvall, Anders Björklund
Jul 6, 2005·The Australian and New Zealand Journal of Psychiatry·M van den BuuseS Kusljic
Jul 9, 2005·Nature Biotechnology·Michael A Laflamme, Charles E Murry
Aug 27, 2005·Journal of Neurosurgery·Douglas KondziolkaJeffrey Teraoka
Oct 27, 2005·Tuberculosis·U D Gupta, V M Katoch
Dec 2, 2005·Journal of Neuropathology and Experimental Neurology·James M PowersKirby D Smith
Jan 4, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·S Thomas Carmichael
Jan 4, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Ibolja Cernak
Jan 4, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Tara L Spires, Bradley T Hyman
Jan 4, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Jia Yi LiPatrik Brundin
Jan 4, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Diane E Merry
Jan 4, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Jordi BovéSerge Przedborski
Jan 4, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Sheila M FlemingMarie-Françoise Chesselet
Jan 19, 2006·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Sheryl S MoyJacqueline N Crawley
Feb 10, 2006·Neurorehabilitation and Neural Repair·Bruce H DobkinJames Guest
Apr 26, 2006·Brain : a Journal of Neurology·Manuel A FrieseLars Fugger
May 3, 2006·The Psychiatric Clinics of North America·Schaun Korff, Brian H Harvey
May 6, 2006·Neuron·Chang-Hyuk KwonLuis F Parada
May 25, 2006·Cell Transplantation·Katherine SoderstromJeffrey H Kordower
May 26, 2006·Nature Reviews. Cancer·Angelo L VescoviBrent A Reynolds
Jun 1, 2006·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Mingyue LiuNabil J Alkayed
Jun 14, 2006·Brain Pathology·Björn SchefflerOliver Brüstle

❮ Previous
Next ❯

Citations

Oct 6, 2009·Bone Marrow Transplantation·G KöglerM Yoder
Jul 10, 2012·BMC Medical Ethics·Ray GreekLawrence A Hansen
Feb 2, 2013·Clinical and Translational Medicine·Anthony P Hollander
Apr 26, 2013·Science and Engineering Ethics·Robert C Jones, Ray Greek
Nov 1, 2011·Studies in History and Philosophy of Biological and Biomedical Sciences·Ray Greek, Niall Shanks
Sep 28, 2010·The Orthopedic Clinics of North America·Eve Blair
Jun 16, 2010·NeuroImage·Ka Yan Karen LeeSteven G Johnson
Jan 1, 2014·Contrast Media & Molecular Imaging·Michel ModoOlivier Clement
Aug 21, 2012·American Journal of Obstetrics and Gynecology·Alan Leviton
Nov 16, 2010·Journal of Vascular Surgery·Robert B McLafferty
Mar 10, 2015·PloS One·Martín A H EscobarCristián F Estades
Mar 4, 2011·Reproduction, Fertility, and Development·Jorge A Piedrahita, Natasha Olby
Jul 7, 2010·Alternatives to Laboratory Animals : ATLA·Orsolya E VargaI Anna S Olsson
Jan 1, 2012·Personalized Medicine·Ray GreekMark J Rice

❮ Previous
Next ❯

Methods Mentioned

BETA
genetic

Clinical Trials Mentioned

NCT00337636

Software Mentioned

EAE

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.